Top Markets
Coin of the day
Edesa Biotech, Inc. Edesa Biotech, Inc.

Edesa Biotech, Inc.

EDSA
Rank in Stocks #25796
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering,... Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Share Price
$4.80
Market Cap
$46.24M
Change (1 day)
-16.52%
Change (1 year)
103.39%
Country
CA
Trade Edesa Biotech, Inc. (EDSA)

Category

Stock split history for Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. stock (symbol: EDSA) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 20, 2026.
One EDSA share bought prior to Aug 20, 2026 would equal to 0 EDSA shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US